Gilead Sciences
GILD
1,575 hedge funds and large institutions have $115B invested in Gilead Sciences in 2015 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 787 increasing their positions, 510 reducing their positions, and 88 closing their positions.
54% more repeat investments, than reductions
Existing positions increased: 787 | Existing positions reduced: 510
33% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 88
1% more funds holding
Funds holding: 1,561 → 1,575 (+14)
0.73% less ownership
Funds ownership: 81.85% → 81.11% (-0.73%)
12% less funds holding in top 10
Funds holding in top 10: 274 → 240 (-34)
19% less capital invested
Capital invested by funds: $141B → $115B (-$26.1B)
34% less call options, than puts
Call options by funds: $2.13B | Put options by funds: $3.23B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$346M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$302M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$245M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$222M |
| 5 |
Morgan Stanley
New York
|
+$217M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$3.33B |
| 2 |
Temasek Holdings
Singapore
|
-$1.04B |
| 3 |
Jennison Associates
New York
|
-$722M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$493M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$478M |
GILD Hedge Fund Activity: Q3 2015 in Review
1,575 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q3 2015, worth a combined $115B — down 19% from $141B a quarter earlier.
Buyers outnumbered sellers: 117 funds opened new GILD positions and 88 closed out — a net gain of 29 holders — while 787 added to existing stakes and 510 trimmed.
The largest buyer was SG Americas Securities, adding an estimated $346M. The largest seller was Capital Research Global Investors, cutting an estimated $3.33B.
- 1,575 institutional investors held Gilead Sciences (GILD) as of Q3 2015, up from 1,561 in Q2 2015.
- Funds reported $115B of Gilead Sciences stock for Q3 2015, down 19% quarter-over-quarter.
- 117 funds opened new Gilead Sciences positions in Q3 2015 and 88 closed out, a net change of +29 holders.
- The largest Gilead Sciences buyer in Q3 2015 was SG Americas Securities, an estimated $346M added.
- The largest Gilead Sciences seller in Q3 2015 was Capital Research Global Investors, an estimated $3.33B sold.
Based on aggregated 13F filings for Q3 2015.